BackBenessere Capital Acquisition - Tradeable Rights - Jan 2021 Overview

Benessere Capital Acquisition - Tradeable Rights - Jan 2021 EBIT

Track Benessere Capital Acquisition - Tradeable Rights - Jan 2021's EBIT ($-3.5M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$989.52K
↓ 336.47% YoY

As of Jun 30, 2022

Annual EBIT (TTM)

-$3.45M

Trailing 12 months ending Jun 30, 2022

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Benessere Capital Acquisition - Tradeable Rights - Jan 2021 (BENER) FAQ

Benessere Capital Acquisition - Tradeable Rights - Jan 2021 posts a EBIT of $-3.5M as of June 2022. That is below the sector sector average of $2.6T. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For its sector stocks, a EBIT near $2.6T is typical. Benessere Capital Acquisition - Tradeable Rights - Jan 2021's $-3.5M is lower that level. That is roughly 100.0% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

EBIT is one piece of Benessere Capital Acquisition - Tradeable Rights - Jan 2021's financial statement story. At $-3.5M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for BENER's EBIT usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $2.6T), and (3) consistency with growth and profitability. This page covers the first two; Benessere Capital Acquisition - Tradeable Rights - Jan 2021's other metric pages and overview cover the third.